87 related articles for article (PubMed ID: 8709907)
1. [Therapeutic strategies in diabetic neuropathy. Pathogenetically founded therapeutic approaches in peripheral, sensory, symmetrical neuropathy].
Luft D
Med Klin (Munich); 1996 May; 91(5):295-301. PubMed ID: 8709907
[No Abstract] [Full Text] [Related]
2. Antidepressants in the treatment of diabetic neuropathy symptoms. Pharmacodynamic, -kinetic, and -genetic aspects.
Sindrup SH
Dan Med Bull; 1994 Feb; 41(1):66-78. PubMed ID: 8187566
[No Abstract] [Full Text] [Related]
3. Does duloxetine safely and effectively reduce the severity of diabetic peripheral neuropathic pain?
Russell JW
Nat Clin Pract Neurol; 2006 Jan; 2(1):18-9. PubMed ID: 16932514
[No Abstract] [Full Text] [Related]
4. ["Diabetic autonomic neuropathy" series. Epidemiology, pathogenesis, basic therapy and prognosis].
Luft D
MMW Fortschr Med; 2002 May; 144(20):47-50. PubMed ID: 12119885
[No Abstract] [Full Text] [Related]
5. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy.
Ekberg K; Brismar T; Johansson BL; Lindström P; Juntti-Berggren L; Norrby A; Berne C; Arnqvist HJ; Bolinder J; Wahren J
Diabetes Care; 2007 Jan; 30(1):71-6. PubMed ID: 17192336
[TBL] [Abstract][Full Text] [Related]
6. Cyclandelate in diabetic neuropathy. A double-blind, placebo-controlled, randomized, cross-over study.
Heimans JJ; Drukarch B; Matthaei I; Ijff GA; Bertelsmann FW; Strijers RL; Nauta J
Acta Neurol Scand; 1991 Dec; 84(6):483-6. PubMed ID: 1665271
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. The Italian Study Group. The St. Vincent Declaration.
Nicolucci A; Carinci F; Cavaliere D; Scorpiglione N; Belfiglio M; Labbrozzi D; Mari E; Benedetti MM; Tognoni G; Liberati A
Diabet Med; 1996 Dec; 13(12):1017-26. PubMed ID: 8973882
[TBL] [Abstract][Full Text] [Related]
8. [Risk factors involved in symmetrical distal diabetic neuropathy].
Gómez-Viera N; Soto-Lavastida A; Roselló-Silva H; Gómez de Molina-Iglesias M
Rev Neurol; 2001 May 1-15; 32(9):806-12. PubMed ID: 11424028
[TBL] [Abstract][Full Text] [Related]
9. Oral zinc therapy in diabetic neuropathy.
Gupta R; Garg VK; Mathur DK; Goyal RK
J Assoc Physicians India; 1998 Nov; 46(11):939-42. PubMed ID: 11229219
[TBL] [Abstract][Full Text] [Related]
10. Medical evaluation and treatment of diabetic peripheral neuropathy.
Petit WA; Upender RP
Clin Podiatr Med Surg; 2003 Oct; 20(4):671-88. PubMed ID: 14636032
[TBL] [Abstract][Full Text] [Related]
11. Effects of cyclandelate on diabetic peripheral neuropathy.
Canal N; Comi G; Marchettini P; Pozza G
Br J Clin Pract Suppl; 1984; 34():62-8. PubMed ID: 6430326
[No Abstract] [Full Text] [Related]
12. Effects of 3-month treatment with the antioxidant alpha-lipoic acid in diabetic peripheral neuropathy.
Negrişanu G; Roşu M; Bolte B; Lefter D; Dabelea D
Rom J Intern Med; 1999; 37(3):297-306. PubMed ID: 15532308
[TBL] [Abstract][Full Text] [Related]
13. Treatment of diabetic polyneuropathy with alpha-lipoic acid is evidence based.
Vereşiu IA
Rom J Intern Med; 2004; 42(2):293-9. PubMed ID: 15529620
[TBL] [Abstract][Full Text] [Related]
14. VEGF gene transfer for diabetic neuropathy.
Isner JM; Ropper A; Hirst K
Hum Gene Ther; 2001 Aug; 12(12):1593-4. PubMed ID: 11529248
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E1 in lipid microspheres ameliorates diabetic peripheral neuropathy: clinical usefulness of Semmes-Weinstein monofilaments for evaluating diabetic sensory abnormality.
Akahori H; Takamura T; Hayakawa T; Ando H; Yamashita H; Kobayashi K
Diabetes Res Clin Pract; 2004 Jun; 64(3):153-9. PubMed ID: 15126001
[TBL] [Abstract][Full Text] [Related]
16. Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials.
Tesfaye S; Tandan R; Bastyr EJ; Kles KA; Skljarevski V; Price KL;
Diabetes Care; 2007 Oct; 30(10):2626-32. PubMed ID: 17623822
[TBL] [Abstract][Full Text] [Related]
17. [Diabetic neuropathies. Basic principles, clinical manifestations and drug therapy].
Reiners K
Zentralbl Chir; 1999; 124 Suppl 1():25-32. PubMed ID: 10436523
[TBL] [Abstract][Full Text] [Related]
18. Diabetic neuropathy.
Gominak S; Parry GJ
Adv Neurol; 2002; 88():99-109. PubMed ID: 11908239
[No Abstract] [Full Text] [Related]
19. Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study.
Rauck RL; Shaibani A; Biton V; Simpson J; Koch B
Clin J Pain; 2007 Feb; 23(2):150-8. PubMed ID: 17237664
[TBL] [Abstract][Full Text] [Related]
20. Diabetic neuropathies: clinical manifestations and current treatment options.
Vinik A; Ullal J; Parson HK; Casellini CM
Nat Clin Pract Endocrinol Metab; 2006 May; 2(5):269-81. PubMed ID: 16932298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
